ATAI · As filed with the SEC
AtaiBeckley income statement, by fiscal year
The statement as AtaiBeckley presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 |
|---|---|---|
| Total revenues | 4,089,000 | 308,000 |
| Research and Development Services Revenue | 3,887,000 | 0 |
| License Revenue | 202,000 | 308,000 |
| Operating expenses: | ||
| Research and development | 53,062,000 | 55,455,000 |
| Acquisition of in-process research and development | 530,000,000 | 0 |
| General and administrative | 65,088,000 | 47,544,000 |
| Total operating expenses | 648,150,000 | 102,999,000 |
| Loss from operations | (644,061,000) | (102,691,000) |
| Other income (expense), net: | ||
| Interest income | 1,478,000 | 778,000 |
| Interest expense | (1,162,000) | (3,124,000) |
| Change in fair value of assets and liabilities, net | (24,416,000) | (48,879,000) |
| Gain on other investments | 3,794,000 | 1,260,000 |
| Gain on consolidation of Beckley Psytech | 6,902,000 | 0 |
| Change in fair value of digital assets, net | (1,233,000) | 0 |
| Foreign exchange loss, net | 1,908,000 | (1,263,000) |
| Other income (expense), net | (3,059,000) | 5,514,000 |
| Other income (expense), net | (15,788,000) | (45,714,000) |
| Net loss before income taxes | (659,849,000) | (148,405,000) |
| Benefit from (provision for) income taxes | (298,000) | 356,000 |
| Losses from investments in equity method investees, net of tax | 0 | (2,000,000) |
| Net loss | (660,147,000) | (150,049,000) |
| Net loss attributable to noncontrolling interests | (100,000) | (780,000) |
| Net loss attributable to ATAI Life Sciences N.V. stockholders | (660,047,000) | (149,269,000) |
| Net loss per share attributable to AtaiBeckley Inc. shareholders - basic | (2.91) | (0.93) |
| Net loss per share attributable to AtaiBeckley Inc. shareholders - diluted | (2.91) | (0.93) |
| Weighted average common stock outstanding attributable to AtaiBeckley Inc. Stockholders - basic | 226,532,786 | 160,159,983 |
| Weighted average common stock outstanding attributable to AtaiBeckley Inc. Stockholders - diluted | 226,532,786 | 160,159,983 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.